Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + esketamine vs propofol + remifentanil for painless fiberoptic bronchoscopy
ChiCTR2100048790Phase 4Recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Jul 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pulmonary diseases comparing Propofol + remifentanil with Propofol + esketamine (2 arms). Primary endpoints: Time of consciousness disappearance and recovery, Ramsay sedation score and 3 more. Started Jul 2021; status: recruiting.
02
Drugs
propofolesketamineremifentanil
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2100048790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048790.